Literature DB >> 25988887

Innate immunity against HIV-1 infection.

Marcus Altfeld1, Michael Gale2.   

Abstract

During acute HIV-1 infection, viral pathogen-associated molecular patterns are recognized by pathogen-recognition receptors (PRRs) of infected cells, which triggers a signaling cascade that initiates innate intracellular antiviral defenses aimed at restricting the replication and spread of the virus. This cell-intrinsic response propagates outward via the action of secreted factors such as cytokines and chemokines that activate innate immune cells and attract them to the site of infection and to local lymphatic tissue. Antiviral innate effector cells can subsequently contribute to the control of viremia and modulate the quality of the adaptive immune response to HIV-1. The concerted actions of PRR signaling, specific viral-restriction factors, innate immune cells, innate-adaptive immune crosstalk and viral evasion strategies determine the outcome of HIV-1 infection and immune responses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25988887     DOI: 10.1038/ni.3157

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  104 in total

1.  IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.

Authors:  Galit Alter; Daniel Kavanagh; Suzannah Rihn; Rutger Luteijn; David Brooks; Michael Oldstone; Jan van Lunzen; Marcus Altfeld
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

2.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.

Authors:  Gilad Doitsh; Nicole L K Galloway; Xin Geng; Zhiyuan Yang; Kathryn M Monroe; Orlando Zepeda; Peter W Hunt; Hiroyu Hatano; Stefanie Sowinski; Isa Muñoz-Arias; Warner C Greene
Journal:  Nature       Date:  2014-01-23       Impact factor: 49.962

3.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

4.  Structural insight into HIV-1 restriction by MxB.

Authors:  Jennifer L Fribourgh; Henry C Nguyen; Kenneth A Matreyek; Frances Joan D Alvarez; Brady J Summers; Tamaria G Dewdney; Christopher Aiken; Peijun Zhang; Alan Engelman; Yong Xiong
Journal:  Cell Host Microbe       Date:  2014-10-09       Impact factor: 21.023

5.  Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.

Authors:  Michelle N Kelly; Mingquan Zheng; Sanbao Ruan; Jay Kolls; Alain D'Souza; Judd E Shellito
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

6.  HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation.

Authors:  Atsushi Okumura; Tim Alce; Barbora Lubyova; Heather Ezelle; Klaus Strebel; Paula M Pitha
Journal:  Virology       Date:  2007-12-20       Impact factor: 3.616

7.  Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins.

Authors:  Jin Qian; Yann Le Duff; Yimeng Wang; Qinghua Pan; Shilei Ding; Yi-Min Zheng; Shan-Lu Liu; Chen Liang
Journal:  Virology       Date:  2014-11-07       Impact factor: 3.616

Review 8.  Toll-like receptors in antiviral innate immunity.

Authors:  Sandra N Lester; Kui Li
Journal:  J Mol Biol       Date:  2013-12-03       Impact factor: 5.469

Review 9.  Interactions between HIV-1 and the cell-autonomous innate immune system.

Authors:  Greg J Towers; Mahdad Noursadeghi
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

10.  Expression profile of host restriction factors in HIV-1 elite controllers.

Authors:  Mohamed Abdel-Mohsen; Rui André Saraiva Raposo; Xutao Deng; Manqing Li; Teri Liegler; Elizabeth Sinclair; Mohamed S Salama; Hussam El-Din A Ghanem; Rebecca Hoh; Joseph K Wong; Michael David; Douglas F Nixon; Steven G Deeks; Satish K Pillai
Journal:  Retrovirology       Date:  2013-10-16       Impact factor: 4.602

View more
  87 in total

1.  Reading the fine print: sequence-specific activation of cGAS.

Authors:  Jessica J Chiang; Michaela U Gack
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

Review 2.  Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.

Authors:  Denise C Hsu; Irini Sereti
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

3.  HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.

Authors:  Lara Manganaro; Elisa de Castro; Ana M Maestre; Kevin Olivieri; Adolfo García-Sastre; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

4.  Insulin-induced gene 1 (INSIG1) inhibits HIV-1 production by degrading Gag via activity of the ubiquitin ligase TRC8.

Authors:  You Zhang; Jing Lu; Jing Ma; Xinqi Liu
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

5.  A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.

Authors:  Mohammad Adnan Siddiqui; Akatsuki Saito; Upul D Halambage; Damien Ferhadian; Douglas K Fischer; Ashwanth C Francis; Gregory B Melikyan; Zandrea Ambrose; Christopher Aiken; Masahiro Yamashita
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

6.  Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers.

Authors:  Ciputra Adijaya Hartana; Yelizaveta Rassadkina; Ce Gao; Enrique Martin-Gayo; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 7.  New targets for HIV drug discovery.

Authors:  Ana C Puhl; Alfredo Garzino Demo; Vadim A Makarov; Sean Ekins
Journal:  Drug Discov Today       Date:  2019-03-15       Impact factor: 7.851

8.  Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.

Authors:  Sudhir Pai Kasturi; Pamela A Kozlowski; Helder I Nakaya; Matheus C Burger; Pedro Russo; Mathew Pham; Yevgeniy Kovalenkov; Eduardo L V Silveira; Colin Havenar-Daughton; Samantha L Burton; Katie M Kilgore; Mathew J Johnson; Rafiq Nabi; Traci Legere; Zarpheen Jinnah Sher; Xuemin Chen; Rama R Amara; Eric Hunter; Steven E Bosinger; Paul Spearman; Shane Crotty; Francois Villinger; Cynthia A Derdeyn; Jens Wrammert; Bali Pulendran
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

9.  Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages.

Authors:  Li Sun; Xu Wang; Yu Zhou; Run-Hong Zhou; Wen-Zhe Ho; Jie-Liang Li
Journal:  Antiviral Res       Date:  2016-08-03       Impact factor: 5.970

10.  Protective Immune Responses Elicited by Deglycosylated Live-Attenuated Simian Immunodeficiency Virus Vaccine Are Associated with IL-15 Effector Functions.

Authors:  Satoru Watanabe; Masayuki Fujino; Yohei Saito; Nursarat Ahmed; Hirotaka Sato; Chie Sugimoto; Tomotaka Okamura; Kenichi Hanaki; Emi E Nakayama; Tatsuo Shioda; Kouji Matsushima; Aftab A Ansari; Francois Villinger; Kazuyasu Mori
Journal:  J Immunol       Date:  2020-08-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.